EASI, (objective) SCORAD and POEM for atopic eczema: Responsiveness and minimal clinically important difference

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 67, Issue 1, 2012, Pages 99-106

  Schram, M E ^a   Spuls, Ph I ^a   Leeflang, M M G ^a   Lindeboom, R ^a   Bos, J D ^a   Schmitt, J ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

atopic eczema; Eczema Area and Severity Index; minimal clinically important difference; outcome measures; Patient Oriented Eczema Measurement and (objective) Severity Scoring of Atopic Dermatitis Index; responsiveness; sensitivity to change

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; METHOTREXATE; PREDNISOLONE;

ADULT; ARTICLE; ATOPIC DERMATITIS; CHILD; DISEASE SEVERITY; ECZEMA AREA AND SEVERITY INDEX; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMAL CLINICALLY IMPORTANT DIFFERENCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SCORING SYSTEM; SEVERITY SCORING OF ATOPIC DERMATITIS; TREATMENT RESPONSE;

ADULT; AREA UNDER CURVE; DERMATITIS, ATOPIC; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; ROC CURVE; TREATMENT OUTCOME;

EID: 83555161727     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2011.02719.x     Document Type: Article

References (21)

1. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998; 351: 1225-1232.
2. Carroll CL, Balkrishnan R, Feldman SR, Fleischer AB Jr, Manuel JC,. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol 2005; 22: 192-199. (Pubitemid 40741251)
3. Schmitt J, Langan S, Williams HC,. What are the best outcome measurements for atopic eczema? A systematic review. J Allergy Clin Immunol 2007; 120: 1389-1398. (Pubitemid 350216596)
4. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993; 186: 23-31.
5. Charman CR, Venn AJ, Williams HC,. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective. Arch Dermatol 2004; 140: 1513-1519. (Pubitemid 39627446)
6. Tofte SJ, Graeber M, Cherill R, Omoto M, Thurston M, Hanifin JM,. Eczema area and severity index (EASI): a new tool to evaluate atopic dermatitis. J Eur Acad Dermatol Venereol 1998; 11: S197.
7. Guyatt GH, Deyo RA, Charlson M, Levine MN, Mitchell A,. Responsiveness and validity in health status measurement: a clarification. J Clin Epidemiol 1989; 42: 403-408. (Pubitemid 19165904)
8. Fletcher A,. Quality-of-life measurements in the evaluation of treatment: proposed guidelines. Br J Clin Pharmacol 1995; 39: 217-222.
9. Breuer K, Braeutigam M, Kapp A, Werfel T,. Influence of pimecrolimus cream 1% on different morphological signs of eczema in infants with atopic dermatitis. Dermatology 2004; 209: 314-320. (Pubitemid 39482623)
10. Schmitt J, Meurer M, Schwanebeck U, Grahlert X, Schakel K,. Treatment following an evidence-based algorithm versus individualised symptom-oriented treatment for atopic eczema. A randomised controlled trial. Dermatology 2008; 217: 299-308.
11. Schmitt J, Schakel K, Folster-Holst R, Bauer A, Oertel R, Augustin M, et al., Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial. Br J Dermatol 2010; 162: 661-668.
12. Schram ME, Roekevisch E, Leeflang MM, Bos JD, Schmitt J, Spuls PI,. A randomized trial of methotrexate versus azathioprine for severe atopic eczema. J Allergy Clin Immunol 2011; 128: 353-359.
13. Revicki D, Hays RD, Cella D, Sloan J,. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 2008; 61: 102-109.
14. Beaton DE, Bombardier C, Katz JN, Wright JG,. A taxonomy for responsiveness. J Clin Epidemiol 2001; 54: 1204-1217. (Pubitemid 34002973)
15. Beaton DE, Katz JN, Fossel AH, Wright JG, Tarasuk V, Bombardier C,. Measuring the whole or the parts? Validity, reliability, and responsiveness of the disabilities of the arm, shoulder and hand outcome measure in different regions of the upper extremity. J Hand Ther 2001; 14: 128-146. (Pubitemid 32463650)
16. Hosmer DW,. Applied Logistic Regression. New York: John Wiley and Sons, 2000.
17. Jaeschke R, Singer J, Guyatt GH,. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10: 407-415. (Pubitemid 20025670)
18. de Winter AF, Heemskerk MA, Terwee CB, Jans MP, Deville W, van Schaardenburg DJ, et al., Inter-observer reproducibility of measurements of range of motion in patients with shoulder pain using a digital inclinometer. BMC Musculoskelet Disord 2004; 5: 18.
19. Mokkink LB, Terwee CB, Knol DL, Stratford PW, Alonso J, Patrick DL, et al., The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol 2010; 10: 22.
20. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al., The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol 2010; 63: 737-745.
21. Crosby RD, Kolotkin RL, Williams GR,. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 2003; 56: 395-407. (Pubitemid 36694091)